The Tide Goes Out on Youth Gender Medicine

The landscape of medical transition for young people is undergoing a significant shift, as established medical guidelines are being reevaluated in light of emerging evidence. For years, the prevailing approach in the United States has been one of affirmation, with major medical associations endorsing “gender-affirming care” – encompassing puberty blockers, hormones, and, in some cases, surgery – for minors. However, recent developments suggest a growing questioning of this approach, driven by concerns about the strength of the evidence supporting these treatments.

A Shift in Medical Consensus

On February 3, the American Society of Plastic Surgeons recommended delaying gender-related surgeries for minors until age 19, citing a lack of clear evidence regarding benefits and risks. The following day, the American Medical Association (AMA) endorsed this view, agreeing that surgical interventions should generally be deferred to adulthood in the absence of robust evidence. This stance echoes long-held concerns from skeptics of youth gender medicine regarding insufficient data on the long-term effects of these procedures.

Did You Know? The American Society of Plastic Surgeons (ASPS) and the American Medical Association (AMA) both explicitly referenced the conclusions of the Cass Report in their recent statements.

These recommendations are not occurring in a vacuum. They align with the findings of both the Cass Report, an independent review of gender identity services in the UK, and a similar evidence review commissioned by the Department of Health and Human Services in the United States. While LGBTQ groups and some gender clinicians initially dismissed these reports as politically motivated, the ASPS explicitly embraces their conclusions.

The Role of the Cass Report

The Cass Report emphasizes that the natural course of gender dysphoria in children remains poorly understood. It suggests that a significant proportion of children experiencing gender dysphoria experience resolution or reduction of distress by adulthood without medical or surgical intervention. This challenges the assumption that a child’s gender identity should be uncritically affirmed and medically transitioned.

Historically, gender surgeries on minors were not performed within Britain’s health service, and a 2023 study indicated that only a few thousand such surgeries had been performed in the United States. While the ASPS statement also notes insufficient evidence for hormone treatments, it does not explicitly recommend against them. However, it does emphasize that surgeons should not rely solely on prior medical interventions or referrals as justification for surgery.

Expert Insight: The shift in recommendations from major medical organizations signals a move away from a purely affirmative model of care, where questioning a patient’s self-identified gender was often discouraged. This represents a growing recognition of the need for more cautious and evidence-based approaches to treating gender dysphoria in young people.

Past Practices and Emerging Concerns

The evolving understanding of youth gender medicine is also informed by cases like that of Chloe Cole, a detransitioner who received a double mastectomy at age 15 and has since testified in favor of state bans on pediatric gender medicine. Similarly, the case of Fox Varian, who received a mastectomy at 16 and later regretted the procedure, resulted in a $2 million settlement after a New York State lawsuit. Varian’s testimony revealed concerns about doctors acting as “enablers” and potentially prioritizing a patient’s stated desires over comprehensive assessment.

The idea of preventing suicide has been a key argument in favor of youth gender medicine, but even this justification is being reexamined. During a Supreme Court hearing, the ACLU’s Chase Strangio conceded that there is no evidence to support the claim that transition prevents suicide, stating that it may reduce suicidal thoughts – a significant departure from previous assertions.

What Might Come Next

The current trend suggests a potential rollback of the purely affirmative approach to youth gender medicine in the United States. Donald Trump has already claimed to have “stopped the mutilation of children,” and 27 states have implemented restrictions on medical transition for minors. Further legal challenges, like the more than two dozen currently underway, could lead to increased scrutiny of affirmative care practices.

As the field faces greater scrutiny, advocates are increasingly emphasizing the need for careful assessments, a practice that was largely rejected by American providers in the 2010s. The focus may shift towards a more cautious approach, prioritizing thorough evaluation and considering the possibility of spontaneous resolution of gender dysphoria.

Frequently Asked Questions

What is the Cass Report?

The Cass Report is an independent review of gender identity services for children and young people commissioned by England’s National Health Service (NHS). It concluded that there was not enough evidence to justify the routine use of Gender Affirmative Medical Treatments (GAMT) for children and adolescents experiencing gender-related distress.

What did the American Medical Association recommend?

The American Medical Association endorsed the American Society of Plastic Surgeons’ recommendation to generally defer surgical interventions for minors with gender dysphoria until adulthood, citing a lack of clear evidence regarding benefits and risks.

What was the role of Johanna Olson-Kennedy?

Johanna Olson-Kennedy, formerly of the Children’s Hospital Los Angeles, authored a paper recommending mastectomies for minors based on “individual need rather than chronologic age” and once stated she did not worry about regret following the procedure.

As medical understanding evolves and the evidence base is more rigorously examined, how will the approach to supporting young people experiencing gender dysphoria continue to adapt?